MELKIN Pharma develops innovative drugs for the treatment of human diseases involving aberrant activation of the MAPkinase/ERK intracellular pathway.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free